Outpost Bio raises $3.5M pre-seed to build AI-driven human microbiology models for pharma, food and consumer product R&D.
Outpost Bio is developing AI-driven models to decode human microbiology by combining automated experiments with machine learning, aiming to help pharma, food, and consumer companies design safer and ...
The National Institute of Standards and Technology’s Artificial Intelligence Safety Institute is seeking information on the development of chemical and biology-focused artificial intelligence models.
Team to develop and validate computational models trained on data from organoids and advanced human model systems that will improve drug safety and reduce reliance on animal testing NEW YORK, Dec. 8, ...
CAMBRIDGE, England--(BUSINESS WIRE)--bit.bio, the company coding human cells for novel cures, and the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London today announce ...
Tuesday, French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and Formation Bio to accelerate drug development projects. Also Read: Drugmaker Sanofi’s Strong Dupixent And ...
Immorta Bio Inc. has reported new data demonstrating that its combination therapy of Senovax, a first-in-class senolytic immunotherapy, and personalized mesenchymal stem cells (pMSCs) from its ...
Following a record Q4 in sales volume and the successful closing of $50 million in new funding, bit.bio is leveraging its economies of scale to substantially lower the price per vial of its ioCells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results